Publication date: Jun 19, 2025
Many countries reported missing and atypical influenza and RSV seasons during the COVID-19 pandemic. Here we describe the incidence and seasonality of COVID-19, influenza, and RSV hospitalizations in Norway between 2017-2024, and the disease burden between 2022-2024. Using nationwide data on ICD-10 discharge codes, procedure codes and laboratory results, we calculate the incidence of COVID-19, influenza, and RSV hospitalizations, by age group, week and surveillance year between January 2017 to April 2024, and report proportions receiving intensive care, deaths and length of stay between 2022-2024. The transmission of influenza and RSV was interrupted the first year of the COVID-19 pandemic and reemerged with epidemics outside of the normal seasonality in 2021/2022, after COVID-19 restrictions were removed. Between 2022-2024, COVID-19 was a greater contributor to hospitalizations than influenza and RSV, with higher mortality rate within two weeks of admission. The use of ventilatory support/intensive care admission was highest among patients hospitalized with RSV. The transmission of influenza and RSV was interrupted during the first year of the COVID-19 pandemic, followed by an unusual seasonality. Although many hospitalizations are caused by RSV and influenza, COVID-19 was the largest contributor of these three to hospital burden in the first years with co-circulation.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Hospitalizations | COVID-19 |
| Influenza | Disease Burden |
| Norway | influenza |
| Surveillance | Length of stay |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | influenza |
| disease | MESH | COVID-19 pandemic |
| disease | MESH | respiratory infections |
| disease | MESH | Infection |
| disease | MESH | Emergency |
| disease | MESH | Communicable Diseases |
| disease | MESH | death |
| disease | IDO | infectious agent |